Cargando…
Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation
BACKGROUND: Total mesorectal excision (TME) remains commonplace for T1–2 rectal cancer owing to fear of undertreating a small proportion of patients with node-positive disease. Molecular stratification may predict cancer progression. It could be used to select patients for organ-preserving surgery i...
Autores principales: | Leong, K J, Beggs, A, James, J, Morton, D G, Matthews, G M, Bach, S P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282074/ https://www.ncbi.nlm.nih.gov/pubmed/25052224 http://dx.doi.org/10.1002/bjs.9571 |
Ejemplares similares
-
Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023) -
Organ Preservation in Rectal Cancer: The Patients' Perspective
por: Gani, Cihan, et al.
Publicado: (2019) -
Mass spectrometry transanal minimally invasive surgery (MS-TAMIS) to promote organ preservation in rectal cancer
por: Mason, Sam, et al.
Publicado: (2019) -
Organ preservation following short-course radiotherapy for rectal cancer
por: Nilsson, Per J, et al.
Publicado: (2021) -
Organ preservation in rectal cancer – Challenges and future strategies
por: Gani, C., et al.
Publicado: (2017)